ProKidney Corp PROK:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
2.19quote price arrow down-0.01 (-0.45%)
Volume
14,383
Close
2.20quote price arrow up+0.05 (+2.33%)
Volume
560,469
52 week range
1.12 - 13.51
Loading...
  • Open2.18
  • Day High2.37
  • Day Low2.03
  • Prev Close2.15
  • 52 Week High13.51
  • 52 Week High Date08/11/23
  • 52 Week Low1.12
  • 52 Week Low Date11/17/23

Key Stats

  • Market Cap509.736M
  • Shares Out231.70M
  • 10 Day Average Volume0.96M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change23.6

KEY STATS

  • Open2.18
  • Day High2.37
  • Day Low2.03
  • Prev Close2.15
  • 52 Week High13.51
  • 52 Week High Date08/11/23
  • 52 Week Low1.12
  • 52 Week Low Date11/17/23
  • Market Cap509.736M
  • Shares Out231.70M
  • 10 Day Average Volume0.96M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change23.6

RATIOS/PROFITABILITY

  • EPS (TTM)-0.57
  • P/E (TTM)-3.85
  • Fwd P/E (NTM)-12.29
  • EBITDA (TTM)-147.669M
  • ROE (TTM)-7.28%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-0.01%

EVENTS

  • Earnings Date05/07/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ProKidney Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ProKidney Corp. is a clinical-stage biotechnology company. The Company is focused on cell therapy platforms capable of treating multiple chronic kidney diseases (CKD) using a patient’s own cells isolated from the patient intended for treatment. The Company’s lead product candidate, Renal Autologous Cell Therapy (REACT), is designed to preserve kidney function in a CKD patient’s diseased kidneys. REACT is a product that includes autologous Selected Renal Cells (SRCs) prepared...
Pablo Legorreta
Chairman of the Board
Bruce Culleton M.D.
Chief Executive Officer, Director
James Coulston CPA
Chief Financial Officer
Ulrich Ernst Ph.D.
Executive Vice President - Technical Operations
Address
2000 Frontis Plaza Blvd., Suite 250
Winston-salem, NC
27103
United States

Top Peers

SYMBOLLASTCHG%CHG
VTGN
Vistagen Therapeutics Inc
4.50+0.09+2.04%
BCAB
Bioatla Inc
3.25+0.09+2.85%
PDSB
PDS Biotechnology Corp
3.82+0.09+2.41%
CTXR
Citius Pharmaceuticals Inc
0.705-0.002-0.2829%
LPTX
Leap Therapeutics Inc
3.19+0.02+0.63%